many categories are impacted by purchase-based decisions made by this unique consumer segment
Specifically, the Beijing IP Court pointed to paragraph [0534] in the specification, which stated: [0534] In one aspect of the invention, the GLP-1 agonist has a duration of action of at least 24 hours after administration to db/db mice at a dose of 30 nmol/kg. According to the Beijing IP Court, the statement the GLP-1 agonist was referring to the entire genus of compounds, and thus was asserting that all the compounds (or at least the 22 examples in the specification) had a duration of action at least 24 hours after administration
The most practical approach is to expect some adjustment, use supportive habits like smaller meals and steady hydration, and communicate early if symptoms become disruptive
Safety: Retatrutide is an investigational compound and is not approved by the FDA
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Changes to menstrual cycles are not listed as specific side effects in the prescribing information for tirzepatide
Theres even discussion about using these drugs in combination with bariatric surgery for better results, or using them in patients with lower BMI but high cardiometabolic risk (some argue that even overweight individuals with conditions like NAFLD or PCOS might benefit)
